TrialInflammopharmacology2022

Advancing combination treatment with glycyrrhizin and boswellic acids for hospitalized patients with moderate COVID-19 infection: a randomized clinical trial.

Adel A Gomaa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.